Takeda Vaccines Inc - EP4153222A1 - Zika Virus Antibody Detection
Summary
Takeda Vaccines, Inc. has obtained European Patent Application EP4153222A1 for a method of detecting Zika virus-specific antibodies. The application names inventors Perez-Guzman, Nascimento, Dean, and Braun and covers IPC classifications spanning immunological preparations, peptides, and nucleic acid detection methods. The patent is designated across 34 European states including Germany, France, the United Kingdom, Italy, and Spain.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.
What changed
EPO has published European Patent Application EP4153222A1 for Takeda Vaccines, Inc., covering methods and compositions for detecting Zika virus-specific antibodies. The patent application spans multiple IPC classifications including immunological preparations, peptides, and diagnostic assay methods.
Diagnostic kit manufacturers, vaccine researchers, and healthcare diagnostic companies operating in designated European states should be aware of this patent scope when developing or commercializing Zika virus detection products. Freedom-to-operate analyses for Zika antibody diagnostics may need to account for this Takeda patent portfolio.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIES
Publication EP4153222A1 Kind: A1 Apr 15, 2026
Applicants
Takeda Vaccines, Inc.
Inventors
PEREZ-GUZMAN, Erick, NASCIMENTO, Eduardo, DEAN, Hansi, BRAUN, Ralph
IPC Classifications
A61K 39/12 20060101AFI20211126BHEP C07K 14/005 20060101ALI20211126BHEP A61K 31/616 20060101ALI20211126BHEP C12N 7/00 20060101ALI20211126BHEP A61K 39/00 20060101ALI20211126BHEP G01N 33/543 20060101ALI20211126BHEP G01N 33/569 20060101ALI20211126BHEP G01N 33/68 20060101ALI20211126BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.